Drug-labels.com

Metoprolol Tartrate Injection, USP: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
1 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Metoprolol Tartrate Injection, USP

ABOUT THIS MEDICATION

What the medication is used for:

Metoprolol Tartrate Injection, USP is used alone or in combination with another medicine for the following conditions:

  • to help to protect the heart after a heart attack (myocardial infarction)

What it does:

Metoprolol Tartrate Injection, USP is a beta-blocker. It helps to control high blood pressure or other heart-related problems.

When it should not be used:

You should not be treated with Metoprolol Tartrate Injection, USP if you:

  • are allergic to metoprolol, to any of the other ingredients in Metoprolol Tartrate Injection, USP or to another beta blocker.
  • have breathlessness, difficulty breathing when lying down, swelling of the feet or legs (signs of a heart disorder).
  • have a slow or irregular heartbeat.
  • have sudden and oppressive chest pain (sign of heart attack).
  • have very poor blood circulation in your limbs (for example, very cold, pale hands or feet, or pain in your leg muscles when you walk).
  • have low blood pressure
  • have non-treated tumor of the medulla of the adrenal glands (pheochromocytoma)
  • have asthma or had history of difficulty breathing with wheezing or coughing.
  • have severe skin problems
  • suffer from severe drop in blood pressure, dizziness, fast heartbeat, rapid and shallow breathing, cold clammy skin (signs of a heart disorder named cardiogenic shock).

What the medicinal ingredient is:

metoprolol tartrate

What the nonmedicinal ingredients are:

Metoprolol Tartrate Injection, USP vials contain: nitrogen,

sodium chloride and water for injection

What dosage forms it comes in:

Metoprolol Tartrate Injection, USP is available as a 1mg/mL solution in single use vials.

WARNINGS AND PRECAUTIONS

BEFORE you use Metoprolol Tartrate Injection, USP talk to your doctor or pharmacist if you:

  • have heart, liver or kidney disease
  • have high or low levels of sugar in the blood (diabetes)
  • are at risk for serious allergic reactions
  • have chest pain when you are at rest.
  • have poor blood circulation in your limbs (for example, very cold, pale hands or feet, or pain in your leg muscles when you walk).
  • have a tumor of the medulla or of the adrenal glands (pheochromocytoma), you would require an additional treatment to Metoprolol Tartrate Injection, USP
  • have an overactive thyroid gland.
  • have respiratory disease such as asthma, or sometimes get breathlessness and wheezing.
  • have a severe syndrome named oculomucocutaneous syndrome whose signs include severe conjunctivitis (red, irritated and watery eye), skin rash and ear infection
  • are pregnant, or intend to become pregnant. Metoprolol Tartrate Injection, USP should not be used during pregnancy. Your doctor will discuss with you the potential risks of taking Metoprolol Tartrate Injection, USP during pregnancy.

  • are breast feeding. If your doctor decides that you must continue to take Metoprolol Tartrate Injection, USP you should stop breast-feeding as metoprolol tartrate passes into breast milk.
  • are under 18 years old.

If you need to undergo an operation where an anesthetic is used, tell your anesthetic professional that you are taking Metoprolol Tartrate Injection, USP.

Driving and using machines: If you experience dizziness, tiredness or blurred vision during your treatment with

Metoprolol Tartrate Injection, USP, do not drive, use machinery, or perform other tasks that need full attention until you know how you respond to Metoprolol Tartrate Injection, USP. Drinking alcohol may increase tiredness.

INTERACTIONS WITH THIS MEDICATION

Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including herbal and non- prescription medicines. Some other medicines may interact with Metoprolol Tartrate Injection USP. These include:

  • medicines used to treat high blood pressure
  • medicines used to treat chest pain (angina) (e.g. nitroglycerin),
  • medicines used to treat irregular heartbeat (e.g. amiodarone, propafenone, quinidine, disopyramidetocainide, procainamide, ajmalineamiodarone, flecainide, digitalis glycosides such as digoxin, lidocaine),
  • anaesthetics, medicines used during surgical operations,
  • adrenaline or similar substances (sympathomimetics) which are found in some eye and nose drops, and in some cough medicines or remedies for the common cold (e.g. noradrenaline, isoprenaline, ephedrine, phenylephrine, phenylpropanolamine, and xanthine derivatives),
  • insulin, or medicines used to treat high levels of sugar in the blood (diabetes),
  • medicines used to relieve pain or inflammation (non-steroidal anti-inflammatory drugs such as COX-2 inhibitors),
  • antibiotics (e.g. rifampicin),
  • antivirals (e.g. ritonavir),
  • antihistamines used to treat hay fever (e.g. diphenhydramine),
  • medicines used to treat malaria (e.g. hydroxychloroquine or quinine),
  • antipsychotic medicines (e.g. thioridazine, , chlorpromazine, fluphenazine, haloperidol),
  • antidepressants (e.g. fluoxetine, paroxetine, fluvoxamine, sertraline, clomipramine, desipramine or bupropion),
  • MOA Inhibitors and adrenergic neuron blockers (e.g. reserpine or guanethidine),
  • antifungals (e.g. terbinafine),
  • ergot alkaloids, used in the prevention and treatment of migraine headaches,
  • dipyridamole, used to reduce the risk of blood clots,
  • alcohol.
  • fingolimod, a medicine used to treat multiple sclerosis
  • Aldesleukin, a medicine used to treat kidney cancer, or other medicines that may cause a decrease in blood pressure

PROPER USE OF THIS MEDICATION

Usual dose:

Metoprolol Tartrate Injection, USP is used for the emergency treatment of heart attacks. It is only used by an experienced health care provider under circumstances where resuscitation and monitoring equipment is available.

Overdose:

Some of the effects of an overdose of Metoprolol Tartrate Injection, USP are: an abnormally slow heartbeat or an irregular heartbeat, very low blood pressure, breathlessness, difficulty breathing when lying down, swelling of the feet, loss of consciousness, blue discoloration of the lips, tongue, skin, seizures, nausea and vomiting, sudden and oppressive chest pain and death.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Like other medications, Metoprolol Tartrate Injection, USP may cause some side effects. These side effects may be minor and temporary. However, some may be serious and need medical attention.

Side effects may include: sleep disturbance, fatigue and tiredness especially with activity, headache, dry mouth, nausea and vomiting, diarrhea or constipation and abdominal pain, numbness, a tingling sensation in the extremities signs of paresthesia, increased sensitivity of the skin to sun, sweating, hair loss, increased weight, and lower back pain.

Based on your health history, your doctor should take blood tests for as long as you are being treated with Metoprolol Tartrate Injection USP.

They may monitor:

  • blood sugar
  • heart, liver, kidney, and thyroid function
  • how Metoprolol Tartrate Injection, USP is affecting other medications that you are taking.

SERIOUS SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Symptom / effectTalk with your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
Common

Low Blood

Pressure:

feeling of

lightheadedness or fainting especially

when getting up from a lying or sitting position

√
Chest Pain√

Bronchospasm:

difficulty breathing with

wheezing or coughing

√

Heart

Failure:

shortness of breath, leg swelling and tiredness especially with activity

√
Uncommon

Edema: ankle

swelling

√

Slow or

irregular

heartbeat

(palpitations)

√

New or

Worsening

Psoriasis:

skin rash (in

the form of

itchy rash,

thickened

patches of

red/silver skin)

√
If you think you, or a person you are caring for, have taken too much Metoprolol Tartrate Injection, USP, contact a healthcare professional, hospital emergency department, or regional poison control centre immediately, even if there are no symptoms.

SERIOUS SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Symptom / effectTalk with your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases

Allergic

Reaction:

rash, hives, swelling of the face, throat, lips,

difficulty swallowing or breathing

√

Liver

Disorder:

yellowing of the skin or eyes, dark

urine, abdominal

pain, nausea,

vomiting, loss of appetite

√

Sexuality:

Abnormal

curvature of

the penis.

Change in

sex drive

Change in

ability to

achieve or

maintain an

erection

√

√

√

Hallucinations:

see or hear things that are not there

√

Depression:

feel sad, loss

of interest in

usual activities

changes in

sleep and

eating patterns

√

Change in

personality

and confusion

√

Visual

Disturbance:

blurred

vision, dry or

irritated eyes

√

SERIOUS SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Symptom / effectTalk with your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases

Hearing

Disturbance:

noises,

reduced or

loss of

hearing

√

Parasthesia:

Colder than

usual hands

or feet

√

Gangrene;

toes or

fingers cold

to the touch,

discoloured

and painful

√

Kidney

Disorder:

change in

frequency of

urination,

swelling of

extremities,

fatigue, skin

rash, itching,

nausea,

vomiting

√

High Blood

Pressure:

headaches,

vision

disorders,

nausea and

vomiting

√

Blood clots:

swelling, pain

and redness

in an arm or

leg that can

be warm to

touch. You

may develop

sudden chest

pain,

difficulty

breathing and

heart

palpitations.

√

SERIOUS SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Symptom / effectTalk with your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases

Decreased

Platelets:

bruising,

bleeding,

fatigue and

weakness

√

Retroperitoneal fibrosis:

lower back

pain, kidney

failure (low

or no urine

produced),

high blood

pressure,

blood clot in

the legs (See

Blood Clots

above)

√

Arthritis:

stiff sore

joints

√

Oculomucocut-aneous

Syndrome:

red, irritated

and watery

eyes, skin

rash and ear

infection

√

This is not a complete list of side effects. For any unexpected effects while taking Metoprolol Tartrate Injection, USP contact your doctor or pharmacist.

HOW TO STORE IT

Store Metoprolol Tartrate Injection, USP vials between 15-30°C. Protect from light.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting
  • (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

If you want more information about Metoprolol Tartrate Injection, USP:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Consumer Information by visiting the Health Canada website (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html); or by calling 1-888-318-0234.

Last Revised: September 22, 2023

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02429152

Revision date stated in the text: September 22, 2023

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Metoprolol Tartrate Injection, USP

Rx or OTC
Prescription (Rx)?
DIN 02429152
Schedule(s) PRESCRIPTION
Active ingredient(s) Metoprolol tartrate 1 MG
Dosage form(s) Solution
Route(s) of administration Intravenous
Drug class (WHO ATC)
  1. C Cardiovascular system drugs
    1. C07 Beta-Adrenergic Blocking Agents
      1. C07A Beta blocking agents
        1. C07AB Beta blocking agents, selective
          1. C07AB02 Metoprolol
Company STRIDES PHARMA CANADA INC
Current status Approved
Current status date August 13, 2020

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.